Skip to main content

Horizon Therapeutics Public Ltd Co

HZNPDelisted Oct 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001492426

Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2021

Institutional positions in Horizon Therapeutics Public Ltd Co as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
571
+47 vs. Q2 2021
Shares held
202.4M
+3.47M (+1.7%) vs. Q2 2021
Total value
$22.2B
+$3.51B (+18.8%) vs. Q2 2021
New holders
86
213 more added
Sold out
39
195 more reduced

3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HZNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 571 institutions
Q1 2021: 516 institutionsQ2 2021: 527 institutionsQ3 2021: 571 institutionsQ4 2021: 609 institutionsQ1 2022: 618 institutionsQ2 2022: 615 institutionsQ3 2022: 528 institutionsQ4 2022: 611 institutionsQ1 2023: 552 institutionsQ2 2023: 516 institutionsQ3 2023: 483 institutionsQ4 2023: 6 institutionsQ1 2024: 1 institutionQ2 2024: 2 institutionsQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ3 2021: $22.2B
Q1 2021: $18.4BQ2 2021: $18.9BQ3 2021: $22.2BQ4 2021: $22.0BQ1 2022: $21.8BQ2 2022: $16.5BQ3 2022: $13.0BQ4 2022: $23.8BQ1 2023: $22.5BQ2 2023: $21.7BQ3 2023: $24.8BQ4 2023: $49.4KQ1 2024: $116Q2 2024: $3.95KQ3 2024: $116Q4 2024: $116Q1 2025: $116Q2 2025: $116Q3 2025: $116Q4 2025: $116Q1 2026: $116Q2 2026: $116
Institutions holding HZNP and their total value by quarter
QuarterHoldersValue
Q2 20261$116
Q1 20261$116
Q4 20251$116
Q3 20251$116
Q2 20251$116
Q1 20251$116
Q4 20241$116
Q3 20241$116
Q2 20242$3.95K
Q1 20241$116
Q4 20236$49.4K
Q3 2023483$24.8B
Q2 2023516$21.7B
Q1 2023552$22.5B
Q4 2022611$23.8B
Q3 2022528$13.0B
Q2 2022615$16.5B
Q1 2022618$21.8B
Q4 2021609$22.0B
Q3 2021571$22.2B
Q2 2021527$18.9B
Q1 2021516$18.4B

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Horizon Therapeutics Public Ltd Co; share changes are against Q2 2021.

Institutions holding HZNP in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Standard Family Office LLC0$00.00%−1,553−100.0%Sold out
Advisory Services Network, LLC0$00.00%−1,150−100.0%Sold out
Fuller & Thaler Asset Management, Inc.0$00.00%−1,021−100.0%Sold out
Sonora Investment Management, LLC0$00.00%−200−100.0%Sold out
Jacobi Capital Management LLC0$00.00%−181−100.0%Sold out
Hartford Financial Management Inc.0$00.00%−100−100.0%Sold out
First Manhattan Co0$00.00%−54−100.0%Sold out
MUFG Americas Holdings Corp0$00.00%−44−100.0%Sold out
Trustcore Financial Services, LLC0$00.00%−24−100.0%Sold out
Summit Wealth Group, LLC0$00.00%−20−100.0%Sold out
Pictet Asset Management Ltd––––Not filed
CWM, LLC––––Not filed
First Horizon Corp––––Not filed